BDNF and major depressive disorder: There is an expanding body of evidence that effective pharmacological treatment in MDD increases levels of circulating BDNF [31,32,33,58] in the hippocampus, in post mortem studies [59], at least in the case of serotonin selective reuptake inhibitors [34].